Cancer incidence for all cancers combined

Cases

New cases of cancer, 2014, UK

 

Higher in men

Incidence rate is higher in males than in females, 2014, UK

 

Trend over time

Cancer incidence rates have increased by 12% since the early 1990s, UK

In 2014, there were 356,860 new cases of cancer in the UK: 180,836 (51%) in males and 176,024 (49%) in females, giving a male:female ratio of around 10:10.[1-4] The crude incidence rate Open a glossary item shows that there are 569 cases for every 100,000 males in the UK, and 537 for every 100,000 females. 

The European age-standardised incidence rate Open a glossary item (AS rate) in males, is significantly higher in Wales and Scotland compared with England and Northern Ireland.[1-4] Rates for females are significantly higher in Scotland than all other constituent countries of the UK, and significantly higher in Wales and England compared with Northern Ireland.[1-4]

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl. C44), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 population, UK, 2014

England Wales Scotland Northern Ireland UK
Male Cases 150,832 9,850 15,668 4,486 180,836
Crude Rate 563.4 647.5 603.4 496.9 568.8
AS Rate 670.8 697.4 693.1 650.1 673.6
AS Rate - 95% LCL 667.4 683.6 682.3 631.1 670.5
AS Rate - 95% UCL 674.2 711.2 704.0 669.1 676.8
Female Cases 146,031 9,269 16,270 4,454 176,024
Crude Rate 530.2 590.1 591.4 474.9 536.6
AS Rate 546.1 560.3 583.3 527.0 549.6
AS Rate - 95% LCL 543.3 548.9 574.4 511.5 547.0
AS Rate - 95% UCL 548.9 571.7 592.3 542.5 552.2
Persons Cases 296,863 19,119 31,938 8,940 356,860
Crude Rate 546.5 618.3 597.2 485.7 552.4
AS Rate 598.3 617.2 628.2 578.1 601.4
AS Rate - 95% LCL 596.2 608.5 621.3 566.1 599.4
AS Rate - 95% UCL 600.5 626.0 635.1 590.1 603.4

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, June 2016. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, May 2016. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, June 2016. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2016. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/

About this data

Data is for: UK, 2014, ICD-10 C00-C97 Excl. C44

The ICD codes for all cancers combined are ICD-10 C00-C97 excluding C44 which includes all malignant neoplasms excluding non-melanoma skin cancer (NMSC). NMSC is often excluded from cancer incidence statistics because it is extremely common and registration is known to be incomplete.

Last reviewed:

Incidence rates for all cancers combined have increased by 12% in the UK since the early 1990s.[1-3] This includes a larger overall increase for females than for males. Cancer incidence rates increased by 15% (persons) in Great Britain between 1979-1981 and 1991-1993.[1-3]

For males, European age-standardised Open a glossary item (AS) incidence rates increased by 4% between 1993-1995 and 2012-2014. For females, rates increased by 16% in this period.[1-3]

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl. C44), European Age-Standardised Incidence Rates, UK, 1993-2014

Over the last decade in the UK (between 2003-2005 and 2012-2014), AS incidence rates for all cancers combined have increased by 7% for males and females combined, with a larger increase for females (8%) than for males (3%).[1-4]

For most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the Office for National Statistics on request, June 2016. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, May 2016. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/ 
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, June 2016. Similar data can be found here: http://www.wcisu.wales.nhs.uk
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2016. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/

About this data

Data is for UK, 1993-2014, ICD-10 (C00-C97 Excl. C44)

Last reviewed:

Overall incidence by stage

A moderate proportion (72-76%) of all cancer cases in England and Northern Ireland have a stage at diagnosis recorded.[1,2]

More cancer patients with a known stage are diagnosed at an early stage (54-55% are diagnosed at stage I or II), than a late stage (45-46% are diagnosed at stage III or IV). Between 25% and 27% of patients have metastases at diagnosis (stage IV).[1,2]

The proportion of cancers diagnosed at each stage varies by cancer type. The stage distribution for each cancer type will reflect many factors including how the cancer type develops, the way symptoms appear, public awareness of symptoms, how quickly a person goes to see their doctor and how quickly the cancer is recognised and diagnosed by a doctor. It might also relate to whether a national screening programme that can detect early stage disease exists for that cancer type, along with the extent of uptake of that programme.

A cancer type associated with a large proportion of early stage diagnoses could be one that is more likely to be symptomatic at an earlier stage of development, with recognisable symptoms rather than more generic ones.

All Cancers Combined (C00-C97 excl. C44), Proportion of Cases Diagnosed at Each Stage, All Ages, England 2014 and Northern Ireland 2010-2014

Data should not be compared between countries due to differences in time periods and possible differences in recording of stage at diagnosis.

References

  1. National Cancer Intelligence Network. Stage Breakdown by CCG 2014. London: NCIN; 2016.
  2. Northern Ireland Cancer Registry, Queens University Belfast, Incidence by stage 2010-2014. Belfast: NICR; 2016

About this data

Data is for: England 2014, Northern Ireland 2010-2014, ICD-10 C00-C97, excl. C44

Data is not comparable between countries due to differences in time periods and possible differences in how countries record stage at diagnosis.

Last reviewed:

All cancers combined incidence rates are projected to rise by 2% in the UK between 2014 and 2035, to 742 cases per 100,000 people by 2035.[1] This includes a smaller increase for males than for females.

For males, all cancers combined European age standardised (AS) Open a glossary item incidence rates in the UK are projected to rise by less than 1% between 2014 and 2035, to 813 cases per 100,000 by 2035.[1] For females, rates are projected to rise by 3% between 2014 and 2035, to 685 cases per 100,000 by 2035.[1]

All Cancers (Excluding Non-Melanoma Skin Cancer, and Including Benign and Uncertain or Unknown Behaviour Brain, other Central Nervous System and Intracranial Tumours: ICD-10 C00-C97 excluding C44 plus D32-D33, D35.2-D35.4, D42-D43, D44.3-D44.5), Observed and Projected Age-Standardised Incidence Rates, by Sex, UK, 1979-2035

 

It is projected that 513,951 cases of all cancers combined (270,261 in males, 243,670 in females) will be diagnosed in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected). ICD-10 codes all cancers combined C00-C97 excluding C44, plus D32-D33, D35.2-D35.4, D42-D43, D44.3-D44.5.

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. The definition of 'all cancer types/sites combined' used here differs from that typically used in incidence statistics on this website: benign and uncertain or unknown behaviour brain, other central nervous system and intracranial tumours (D32-D33, D35.2-D35.4, D42-D43, D44.3-D44.5) are included here. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

An estimated 2,273,200 people who had previously been diagnosed with cancer were alive in the UK at the end of 2013.[1]

Among specific cancer types, female breast cancer has the highest prevalence, because it has high incidence and survival.

References

  1. Macmillan Cancer Support and National Cancer Registration and Analysis Service. UK complete cancer prevalence for 2013 workbook. London: NCRAS; 2016.

About this data

Data is for: All UK patients who had been diagnosed with cancer at any time before 31st December 2013, ICD-10 C00-C97 excluding C44

Last reviewed:

The UK incidence rate for all cancers combined (excluding non-melanoma skin cancer) in males is lower (9%) than those in the European Union (284 and 311 per 100,000, respectively), but the rate is higher (11%) in females in the UK than those in the EU (267 and 241 per 100,000, respectively).[1]

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr accessed August 2015.
 
Last reviewed:

The incidence rate for all cancers combined (excluding non-melanoma skin cancer) for males in the UK is lower (8%) than in the more developed regions (MDRs) of the world (284 and 307 per 100,000, respectively), but is higher (11%) for females in the UK than in the MDRs (267 and 240 per 100,000, respectively).[1]

The incidence rates for all cancers combined (excluding non-melanoma skin cancer) for both sexes in the UK are higher (74% in males and 97% in females) than the less developed regions (LDRs) of the world (163 and 136 per 100,000 for males and females, respectively).[1]

The four most common types of cancer worldwide are also the most common types of cancer diagnosed in the UK.[1]

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr accessed August 2015.
Last reviewed:

Local Cancer Statistics

Find and compare local statistics and information in the UK by healthboard, Local Authority or postcode.

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Rate this page:

Currently rated: 1.9 out of 5 based on 13 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page